Novel Antiseptic Urinary Catheters for Prevention of Urinary Tract Infections: Correlation of In Vivo and In Vitro Test Results

Ray Hachem(The University of Texas MD Anderson Cancer Center), Issam Raad(Missouri Department of Agriculture), Rajesh Uthamanthil(The University of Texas MD Anderson Cancer Center), Peggy T. Tinkey(The University of Texas MD Anderson Cancer Center), Agatha Borne(The University of Texas MD Anderson Cancer Center), Mahmoud A. Ghannoum(Case Western Reserve University), Ying Jiang(The University of Texas MD Anderson Cancer Center), Jyotsna Chandra(The University of Texas MD Anderson Cancer Center), Ruth Reitzel(The University of Texas MD Anderson Cancer Center)
Antimicrobial Agents and Chemotherapy
October 5, 2009
10.1128/aac.00718-09
Cited by 90

Related Papers

Clinical Practice Guidelines for the Diagnosis and Management of Intravascular Catheter-Related Infection: 2009 Update by the Infectious Diseases Society of America
|Clinical Infectious Diseases|2009|3.6k
Guidelines for the Management of Intravascular Catheter-Related Infections
|Clinical Infectious Diseases|2001|1.5k
Development of Interpretive Breakpoints for Antifungal Susceptibility Testing: Conceptual Framework and Analysis of In Vitro-In Vivo Correlation Data for Fluconazole, Itraconazole, and Candida Infections
|Clinical Infectious Diseases|1997|863
A Comparison of Two Antimicrobial-Impregnated Central Venous Catheters
|New England Journal of Medicine|1999|806
Treatment of Invasive Aspergillosis with Posaconazole in Patients Who Are Refractory to or Intolerant of Conventional Therapy: An Externally Controlled Trial
|Clinical Infectious Diseases|2006|752